UK regulator to shame companies for misleading advertisementsBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7489.436-a (Published 24 February 2005) Cite this as: BMJ 2005;330:436
- Liza Gibson
The UK drug agency, the Medicines Healthcare Products Regulatory Agency, says it will be “naming and shaming” pharmaceutical companies that produce misleading promotional material. The drug industry will now have to comply with new “tougher” guidance aimed at poor practice.
Companies that regularly breach the guidelines will be subject to a review of their whole advertising portfolio to ensure they meet …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial